INTRODUCTION
Transactive response DNA-binding protein 43 (TDP-43) is a highly conserved, ubiquitously expressed heterogeneous ribonucleoprotein (hnRNP) that is primarily nuclear but shuttles between the cytoplasm and nucleus. TDP-43 was initially identified as a transcription repressor (Ou et al., 1995) and splicing regulator (Buratti et al., 2001 ) and later recognized as the major component of pathological cytoplasmic inclusions characteristic of frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS), and inclusion body myopathy (Neumann et al., 2006) . Dominant mutations in TDP-43 are sufficient to cause familial forms of those diseases, underscoring its role in pathogenesis (Al-Chalabi et al., 2012) . The identification of mutations in related RNA processing proteins has focused interest on perturbed RNA metabolism as a potential common defect underlying neurodegenerative diseases (Kim et al., 2013; Kwiatkowski et al., 2009; Ramaswami et al., 2013) , yet the role(s) of TDP-43 in RNA metabolism is far from complete. How disease-causing mutations disrupt TDP-43 function(s), the relative contribution of toxic gain versus loss of function to disease, and the cellular compartment(s) in which this perturbation occurs, remains to be determined.
TDP-43 binds to thousands of mRNAs, many of which are important in brain development and synaptic function, but regulates alternative splicing of a small subset of these (Polymenidou et al., 2011; Tollervey et al., 2011; Xiao et al., 2011) . Isolation of TDP-43 from a cytoplasmic fraction of human brain revealed binding to the 3 0 UTR of numerous target mRNAs, suggesting a role in mRNA stability and/ or transport (Tollervey et al., 2011) . TDP-43 copurifies with proteins involved in RNA transport (Freibaum et al., 2010) , is trafficked in neurons (Fallini et al., 2012; Wang et al., 2008) , and is detected in distal compartments such as the presynaptic membrane of axon terminals in the neuromuscular junction in mice (Narayanan et al., 2013) . As such, it has been suggested that TDP-43 plays a role in the transport of certain target mRNAs into distal neuronal processes, but direct evidence is lacking . The extent to which this hypothetical function might be compromised by disease mutations has not been explored.
RESULTS

Axonal Trafficking of TDP-43 Granules in Drosophila
Motor Neurons Is Impaired by ALS Mutations TDP-43 is highly conserved throughout the animal kingdom, and knockout of the gene encoding TDP-43 is lethal in mouse (Sephton et al., 2010) . We used several model systems, including Drosophila, mouse, and human stem cell-derived motor neurons to systematically study TDP-43 function and the consequence of disease mutations. Drosophila that lack TBPH, the TDP-43 ortholog, typically die as pupae and escapers exhibit motor neuron synaptic dysfunction, progressive loss of motor neurons, and reduced lifespan Feiguin et al., 2009; Vanden Broeck et al., 2013) . This loss-of-function phenotype can be rescued by stably introducing wild-type human TDP-43 (TDP-43 WT ), illustrating conservation of TDP-43 function and validating Drosophila as a relevant model system (Figure S1A available online). By contrast, introduction of TDP-43 harboring ALS-causing mutations (TDP-43 M337V ) at equivalent expression levels fails to rescue the motor neuron defect ( Figure S1A ), suggesting that at least one consequence of disease-causing mutation is partial loss of function. To study TDP-43 in Drosophila in more detail, we used PhiC31 integrase-mediated transgenesis to generate animals expressing equal levels of fluorescently tagged TDP-43 WT , or either of the two ALS-causing mutants TDP-43 M337V or TDP-43 A315T , and monitored protein localization in motor neurons of animals with matched total expression levels ( Figures S1G and S1H ). The distribution of TDP-43 WT was primarily nuclear as expected (Figures S1B, S1C, and S1G), but we also observed numerous cytoplasmic granules along the length of axons and extending into the neuromuscular junction (NMJ), where TDP-43 fluorescence was diffuse ( Figure S1G ). By contrast, TDP-43 M337V and TDP-43 A315T accumulated in the cell soma and proximal axons (Figures S1B-S1D) but was absent or reduced at distal axons and the NMJ ( Figures S1E and S1F ). Live imaging of Drosophila motor neurons revealed that both wild-type (Movie S1) and mutant TDP-43 granules were transported bidirectionally for long distances with brief pauses ( Figure 1A ). We also observed that mutant TDP-43 granules were not transported efficiently along neuronal axons and displayed a less continuous movement that is evident when plotted using kymographs ( Figures 1A-1F ). The marked difference in subcellular distribution and transport behavior of wild-type and mutant TDP-43 prompted us to analyze the kinetics of TDP-43 transport in motor neurons. We observed a significant reduction in net anterograde displacement of TDP-43 M337V and TDP-43 A315T granules relative to respectively; Figure 1G ; Table S1 ). Interestingly, we also observed that a greater fraction of TDP-43 M337V and TDP-43 A315T granules moved in the retrograde direction relative to TDP-43 WT granules ( Figure 1I ). These data suggest impaired anterograde movement of TDP-43 M337V and TDP-43 A315T granules along motor neuron axons in vivo, leading to mutant TDP-43 accumulation in the cytoplasm and proximal axons and deficiency at the NMJ.
Axonal Trafficking of TDP-43 Granules in Mouse Cortical Neurons Is Selectively Impaired by ALS Mutations
The presence of TDP-43 in cytoplasmic granules in vivo that are dynamic and transported along axons in Drosophila prompted us to study the biology of these motile granules in primary mouse cortical neurons. Under normal conditions, endogenous TDP-43 was predominantly nuclear, as described previously (Barmada et al., 2010) , though cytoplasmic puncta in neurites were also observed in most cells ( Figure S2A ). Exogenous expression of mCherry-TDP-43 WT showed the same (Table S1 ) were consistent with microtubule-dependent fast axonal transport. TDP-43 granule movement was unaffected by treatment with latrunculin, which disrupts actin filaments, but abolished by treatment with nocodazole, which disrupts microtubules ( Figure 2C ). This microtubule-dependent transport of TDP-43 granules is consistent with long-range axonal transport of protein complexes in neurons (Brown, 2013) . To determine whether the ALS-causing mutations in TDP-43 influence granule trafficking, we compared trafficking parameters in neurons transfected with mCherry-TDP-43 WT , mCherry-TDP-43 M337 , or mCherry-TDP-43 A315T . Although the granule transport instantaneous velocities were indistinguishable, mCherry-TDP-43 M337 and mCherry-TDP-43 A315T granules were more frequently immotile (p = 0.036 and 0.0027, respectively) and reversed direction significantly more frequently (p = 0.0017 and 0.0032, respectively; Figures 2D and 2E). These altered trafficking parameters of mutant TDP-43 granules were reflected in significant reductions in net displacement of TDP-43 M337V and TDP-43 A315T (TDP-43 M337V : p < 0.001 in both directions; TDP-43 A315T : p = 0.030 anterograde and 0.045 retrograde; Figure 2F ; Table S1 ). Interestingly, we observed a significant increase in retrograde movement of mutant TDP-43 granules as compared to wild-type (TDP-43 M337V : p = 0.037; TDP-43 A315T : p = 0.042; Figure 2H ). To determine whether TDP-43 mutations result in generalized disruption of anterograde transport, we monitored mitochondrial trafficking and TDP-43 granule trafficking simultaneously in the same cells. In primary cortical neurons, axonal transport of mitochondria was indistinguishable between cells expressing WT or mutant TDP-43 (M337V or A315T mutants) at 5-7 days in culture (Figures 2G and 2I;  Table S1 ) despite a significant defect in axonal transport of TDP-43 granules. We conclude that TDP-43 mutation results in a selective defect in the trafficking of TDP-43-containing granules, although this could lead to broader cellular toxicity and a more generalized defect in axonal transport in neurons cultured for longer periods of time . 
TDP-43 Is a Component of Trafficked mRNP Granules and Facilitates Trafficking of Cognate mRNA
We and others have shown that TDP-43 interacts with a network of RNA-binding proteins (Fallini et al., 2012; Freibaum et al., 2010; Ling et al., 2010) . The TDP-43 interactome includes numerous proteins involved in RNA trafficking, suggesting that some fraction of TDP-43 is a component of mRNP granules transported along neuronal axons. TDP-43 coimmunopurifies and colocalizes with the RNA trafficking protein Staufen ( Figures S3A and S3B) . Further, we determined that actively transported axonal TDP-43 granules stain positively with SYTO RNASelect Green fluorescent stain, consistent with the notion that TDP-43 granules transported along axons of cortical neurons contain RNA ( Figure S3C) .
A limitation of SYTO RNASelect stain is that it is a nonspecific, general RNA dye. To investigate the association of TDP-43 with one of its well-characterized mRNA targets, we designed an ''mRNA beacon'' consisting of a Cy3-tagged oligonucleotide that specifically hybridizes to mouse or human Neurofilament-L (Nefl or NEFL, respectively) mRNA and studied mRNA trafficking in live cells ( Figure 3A ; Figures S3D and  S3E ). Neurofilament-L mRNA has a consensus TDP-43 binding site in its 3 0 UTR and binds TDP-43 in extracts from human and mouse brain tissue (Polymenidou et al., 2011; Volkening et al., 2009) . Fluorescence emission from the mRNA beacon is quenched until hybridization to Nefl mRNA and conjugation to a NeutrAvidin polypeptide prevents accumulation of beacon in the nucleus (Figure 3A ; Figure S3E ). Live fluorescent imaging of mouse cortical neurons showed that Nefl mRNA is present throughout the axonal compartment and can be observed distally, even in the growth cones ( Figures 3B and 3C) . Nefl mRNP granules moved bidirectionally along axons with intermittent rapid movements indistinguishable from those of TDP-43 granules ( Figure 3D ; Movie S2). Nefl mRNP granules existed in two fractions: those colocalized with fluorescently labeled TDP-43 ( Figure 3E ) and those without any TDP-43 staining. Importantly, these two fractions showed different trafficking behavior. Specifically, Nefl mRNP granules that contained TDP-43 showed net anterograde movement, whereas those Nefl mRNP granules without TDP-43 showed net retrograde movement ( Figure 3F ). We conclude that TDP-43 is specifically associated with mRNP granules that promote anterograde transport of certain mRNAs, is a marker of such granules, and could even participate in this process.
Defective Trafficking of TDP-43 Cognate mRNA in Motor Neurons Derived from ALS Patients with TDP-43 Mutations
The data derived from Drosophila motor neurons and mouse cortical neurons consistently show that TDP-43 granules undergo bidirectional transport and that this is selectively impaired by ALS-causing mutations in TDP-43. These data were generated by monitoring the trafficking of exogenous, fluorescently-tagged TDP-43. While this is standard in the trafficking field, there remains a possibility that overexpression of TDP-43 influences its behavior in these assays. The mRNA beacon that we describe here, combined with recent advances in induced pluripotent stem (iPS) cell technology to generate motor neurons from ALS patients, affords a novel opportunity to corroborate our results in a relevant human cell type with endogenous wildtype or mutant TDP-43 expressed at physiological levels. Thus, we analyzed NEFL transport in iPS cell-derived human motor neurons carrying both of the ALS-causing mutations we analyzed in Drosophila and mouse cortical neurons (M337V and A315T) and one additional ALS-causing mutation (G298S). The cells derived from an ALS patient with the M337V mutation were described previously (Bilican et al., 2012) . These motor neurons exhibit increased cytoplasmic TDP-43 in the soma, accumulation of insoluble TDP-43, and accelerated cell death relative to control cells (Bilican et al., 2012) . We monitored the movement of NEFL mRNP granules in axons of HB9-positive control or ALS motor neurons (TDP-43 M337V ; patient 31) in three time windows over 2 consecutive weeks after plating and prior to the observation of cell toxicity. NEFL mRNP granules underwent bidirectional, rapid movements that were interrupted by brief pauses in the axons of control and ALS motor neurons ( Figure 4B ; Movie S3). The cells were monitored for a period of 2 weeks, after which it was not possible to clearly recognize individual axonal tracks extending from the cell soma to the growth cones without obstruction by glial cells or a significant decrease in the fluorescent intensity of the mRNA beacon. During the first week after plating, granule transport velocities, net displacement, and directionality were indistinguishable between control and ALS motor neurons. By days 9-13, a defect in the transport of NEFL mRNP granules became apparent in ALS motor neurons. Specifically, anterograde transport of the NEFL mRNP granules significantly decreased ( Figure 4C ). The frequency of reversals and the overall fraction of retrogradely moving granules also increased significantly in the ALS motor neurons (p = 0.011 and p = 0.028, respectively), demonstrating less efficient transport mechanisms of NEFL mRNA ( Figures  4C, 4E, and 4F) .
Given the inherent variability in motor neurons differentiated from human iPS cells, we generated additional control (Control line 2; patient 11 [Boulting et al., 2011] ) and mutant iPS cell lines (TDP-43 G298S and TDP-43 A315T ; patients 47 and RB20, respectively) ( Figure 4A ; Figure S4 ). Examining these additional cell lines permitted us to determine whether impaired TDP-43 granule trafficking is solely a consequence of the M337V mutation or occurs more broadly with other TDP-43 mutations. In these cells, we monitored the movement of NEFL mRNA granules in four time windows over 17 days after plating. Our results again showed significant decrease in anterograde displacement that was quite profound 10 days after plating and becomes progressively worse with time (Figure 4D ). We observe a significant increase in the frequency of reversals and retrograde movement of NEFL mRNA granules in iPS cell-derived motor neurons from ALS patients as compared to wild-type after 9 days in culture ( Figures 4D  and 4E ).
DISCUSSION
Here we establish that TDP-43 is a component of mRNP transport granules in neurons, including human stem cell-derived motor neurons, and identify a new role for TDP-43 in the cytoplasm supporting anterograde axonal transport of target mRNAs from the soma to distal axonal compartments, including the NMJ. We also establish that three different ALS-causing mutations of TDP-43 impair this cytoplasmic function. This partial loss of function is consistent with the inability of mutant TDP-43 to complement a deficiency of endogenous TBPH in Drosophila. This transport defect is specific for TDP-43-positive mRNP granules, since another microtubule-dependent cargo in the same cells is transported normally during the same observation window. We conclude that deficient axonal transport of mRNA targeted by TDP-43 may contribute to pathogenesis of ALS and related diseases such as FTD.
Given the dominant inheritance of TDP-43 mutations in ALS, this defect in TDP-43 trafficking is unlikely to be the sole contribution of mutant TDP-43 to disease. Nevertheless, this clear and consistent defect in TDP-43 granule transport is likely an important contributor to ALS, perhaps influencing specific disease features such as cell-type specificity or the pattern of degeneration. ALS has been described as a ''distal axonopathy'' because morphological abnormalities of the distal axon, including dismantling of the NMJ leading to denervation, are among the earliest pathological features (Fischer et al., 2004) . Many of the mRNA targets of TDP-43 encode proteins that function in this compartment but only a subset show differential splicing with altered TDP-43 levels or TDP-43 mutations (Lagier-Tourenne et al., 2012; Polymenidou et al., 2011) . One might speculate that a failure of TDP-43 to adequately support spatially appropriate translation of target mRNAs could contribute to this pattern of neurodegeneration.
The mechanism whereby disease-causing mutations impair granule transport is unclear but could involve a defect in the ability of mutant TDP-43 granules to engage motor proteins or a physical impediment to their movement based on some abnormality in their size or shape. However, it is worth noting that these disease mutations all impact a prion-like domain in the C terminus of TDP-43. Prion-like domains in TDP-43 and related RNA-binding proteins mediate the assembly of RNA granules, and disease mutations in these prion-like domains disturb the dynamics of RNA granule assembly and disassembly (Ramaswami et al., 2013) . Normally, RNA transport granules in neurons are highly dynamic (Barbee et al., 2006) and this relates to their ability to deliver mRNAs to distal sites for local translation (Krichevsky and Kosik, 2001 ). The correlation between the impairment of RNA granule dynamics and impairment of RNA granule transport by ALS mutations suggests the possibility of a heretofore unappreciated role for RNA granule dynamism and transport that will require additional research to elucidate. The important take home messages from this study are that TDP-43 has a cytoplasmic function that is impaired by disease-causing mutations; TDP-43 is a component of neuronal RNA transport granules; association of target mRNAs with TDP-43 correlates with their anterograde transport; and ALS-causing mutations in TDP-43 impair this transport in vivo in Drosophila, in mouse cortical neurons, and in iPS-derived motor neurons from ALS patients.
EXPERIMENTAL PROCEDURES Drosophila
Third-instar Drosophila larvae genotypes OK371 > Gal4/ UAS-Venus-TDP-43 WT, OK371 > Gal4/ UAS-Venus-TDP-43 M337V, and OK371 > Gal4/UAS-YFP-TDP-43 A315T were used for axonal transport imaging. For TDP-43 quantification at the cell body and synaptic terminal, UAS-CD8-RFP (Bloomington Stock Center; stock 27391) was coexpressed, resulting in the genotypes: OK371 > Gal4, UAS-CD8-RFP/ UAS-TDP-43 WT or OK371 > Gal4, UAS-CD8-RFP/ UAS-TDP-43 M337V, OK371 > Gal4, UAS-CD8-RFP/UAS-TDP-43 A315T, and negative control-OK371 > Gal4, UAS-CD8-RFP/+. OK371-Gal4 driver was used for all Drosophila transgene expression except for the TBPH rescue cross where Armadillo Gal4 was used. In TBPH viability rescue cross, transgenes (UAS-Venus-TBPH, UAS-Venus-TDP-43, and UAS-Venus-TDP43 M337V) were expressed by Armadillo Gal4 in TBPH D23 homozygote mutants. Controls in this analysis included W1118, homozygotes, and heterozygotes for the null TBPH D23 mutation. Third-instar larvae were sorted by genotype and placed in separate vials. The percentage of larvae that became living adults was recorded and graphed.
Mouse Primary Neuron Culture and Transfection
Primary mouse cortical neuron culture and transfection were conducted as previously described (Kaech and Banker, 2006) . Details are provided in Supplemental Experimental Procedures.
Confocal Imaging
Imaging cortical neurons was done 5-8 days after plating, and human motor neurons 2-17 days after plating. For in vivo live imaging, wandering third-instar Drosophila larvae were dissected live in HL3 medium (Stewart et al., 1994) ; pinned to Sylgard in an imaging chamber; eviscerated keeping CNS, nerves, and muscle intact; and covered with a coverslip. Time-lapse movies were obtained using a spinning-disc confocal Marianas system (Intelligent Imaging Innovations) configured on a Zeiss Axio Observer. Further details can be found in Supplemental Experimental Procedures.
Image and Movie Analysis
In live Drosophila larvae samples, images of the NMJ at muscle 13 were examined for levels of Venus-TDP-43 fluorescence. Time-lapse movies were analyzed using SlideBook 5.5 or Imaris 7.6 (Bitplane Science Software) with the manual particle-tracking module. Granules that moved >3 mm during the length of the movie were analyzed. In mouse cortical neurons, when granules changed direction, they were considered a new particle. However, in the moving versus stationary analysis, granules changing direction were counted as one moving particle.
Imaging Mitochondrial Transport
For live-cell imaging of mitochondria, cells transfected with fluorescent TDP-43 (wild-type or mutant) were incubated for 20 min in imaging media containing either Mitotracker Red FM (25 nM; Invitrogen) or Mitotracker Green FM (20 nM; Invitrogen). The cells were then imaged using live fluorescent confocal microscopy as described above.
Coimmunoprecipitation FLAG-tagged expression plasmids were transfected into HEK293T cells using Fugene 6 as recommended by manufacturer. Mock-transfected cells were used as negative control, and a 10 cm plate was used for each coimmunoprecipitation. Forty-eight hours later, cells were lysed and lysates were cleared by centrifugation at 21,000 3 g. Clarified lysates were precleared with normal mouse IgG agarose and protein G agarose prior to coimmunoprecipitation with anti-FLAG (M2, Sigma) agarose. Beads were washed and immmunopurified proteins were eluted with FLAG peptide (Sigma). Proteins were separated by SDS-PAGE prior to protein identification by mass spectrometry. Where indicated, 45 mg RNase A was added to each lysate prior to coimmunoprecipitation.
Western Blotting
To study the interaction between Stau1 and TDP-43, we separated samples by SDS-PAGE using AnyKD tris-glycine gels (Bio-Rad) and transferred them to PVDF membrane. To detect expression levels of TDP-43, we collected, homogenized, and reduced per lane three Drosophila third-instar larvae brains. These samples were separated by SDS-PAGE using Novex NuPAGE Bis-Tris (Life Technologies) gels. Anti-TDP43 (Santa Cruz, sc-100871) and anti-STAU1 (ProteinTech, 14225-1-AP) were used.
mRNA Beacon Design, Synthesis, and Testing Beacon loop sequences of 23-25 nt were designed manually to detect the mouse or human NFL transcript using three different programs in parallel: (1) OLIGOWALK, (2) mFold, and (3) MicroInspector. Using this approach, beacons were predicted to stably hybridize to single-stranded regions of the transcript in areas not bound by endogenous microRNAs (Bratu et al., 2003) . Beacons were synthesized using a nuclease-resistant 2 0 -O-methylribonucleotide backbone and were prevented from nuclear localization by conjugation to NeutrAvidin (Chen et al., 2009 (Chen et al., , 2010 . Beacons were synthesized with a biotinmodified-dT nucleotide in the 3 0 stem sequence and were labeled with 5 0 Cy3 and 3 0 BHQ2 by Sigma Aldrich. The beacon sequences are Nefl
sequences form the self-hybridizing stem sequence and uppercase letters hybridize to the transcript. Nefl beacon hybridization to its target sequence was tested in vitro using synthetic oligonucleotides in solution. Nefl beacon hybridized rapidly with its target and high specific fluorescence was detected.
Further details are provided in Supplemental Experimental Procedures.
Generation and Characterization of TDP-43 iPS Cell Lines iPS cell lines characterized in this study were TDP-43 A315T and TDP-43 G298S . Dermal biopsies were obtained from two familial ALS patients with mutations in the TARDBP locus. From these explants, fibroblasts were generated and expanded in KO-DMEM (Life Technologies) supplemented with 10% FBS (Hyclone). TDP-43 iPS cells were derived by transduction of fibroblasts with retroviruses expressing OCT4, SOX2, and KLF4. After 3-4 weeks, primary iPS cell colonies were picked based on morphology and independently expanded in mTeSR 1 medium (STEMCELL Technologies) to generate four to six different iPS cell lines/patient. The presence of the mutations was confirmed by PCR amplification of a genomic region surrounding Exon 6, followed by Sanger DNA sequencing. The pluripotency of the iPS cell lines used was validated using the TaqMan hPSC Scorecard Panel (Life Technologies). Expression of transcription factors and cell surface antigens characteristic of the pluripotent state was confirmed using immunocytochemistry. Primary antibodies and dilution factors used for this purpose were NANOG (1:100, R&D), OCT3/4 (1:500, Santa Cruz), SSEA-4 (1:1,000, Santa Cruz), and TRA-1-81 (1:1,000, Millipore).
iPS and Derived iPS Motor Neurons
Detailed description can be found in the Supplemental Experimental Procedures section. Briefly, iPS cells were maintained on a monolayer of neomycin-selected mouse embryonic fibroblasts (MEFs; Millipore) in hiPS media (Bilican et al., 2012; Dimos et al., 2008) . To generate motor neurons, we incubated undifferentiated iPS cells with 10 mM Y27632 (Calbiochem), then passaged, triturated, and placed them into ultra-low adherent culture dishes (Corning) for seeding of embryoid bodies (EBs). For the first 11 days, cells were kept in suspension in hiPS media without bFGF. At day 11, EBs were switched to neural induction medium. At day 28, EBs were dissociated, transfected using Lonza Nucleofector with mRNA beacons and HB9 (9Kb)-promoter-GFP, and plated onto PDL/laminin-coated (BD Biosciences) glass (Kaech and Banker, 2006) . To prepare the cells for live imaging, we allowed cells to settle on glass coverslips flipped over primary glial monolayers.
Statistical Analyses
Statistical analyses were performed with Prism6 (GraphPad Software).
Comparing the TDP-43 wild-type to mutant TDP-43 data sets yielded all p values. A Mann-Whitney unpaired test with one-tailed p value was completed for comparing distances traveled, velocity analysis, and the directional percentages of granules within populations. A one-way ANOVA test followed by a Tukey test was completed for the TBPH rescue analysis. KaleidaGraph (Synergy Software) was used to make the axonal particle trafficking distance and velocity bar graphs. All error bars are shown as mean ± SEM.
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